Growth Looks Great Until You Strip Out the FCNR
PAT jumped 21.4%, loans grew 30%, but $18 billion in foreign deposits masks a deeper slowdown. Margins are compressing, guidance is silent, and the street has loaded in all the upside.
₹17,312 Cr
+21.4% YoY
4.18%
−18 bps QoQ from 4.36%
30% YoY
₹24% ex-FCNR
27.1% YoY
₹17% ex-FCNR; $18B FCNR injected
On paper, ICICI Bank delivered a blowout: net profit rose ₹17,312 crore (up 21.4% year-on-year), loans grew 30%, and deposits grew 27.1%. But three-quarters of that growth came from a single $18 billion foreign-currency deposit inflow. Exclude that, and the bank's core momentum—loan growth of 24%, deposit growth of 17%—is healthy but not exceptional. More important, net interest margins compressed 18 basis points quarter-on-quarter, and management said that pain is only beginning.
The FCNR windfall and what it masks
ICICI mobilized $18 billion in FCNR (foreign-currency non-resident) deposits, the largest such fundraise in the peer set. It's a real source of stable funding—a 3-to-5-year tenor from NRI customers—and it did fund the loan growth you see in the headline. But it also did something the headline profit doesn't scream: it depressed margins. FCNR deposits cost 6.5% (including hedging); they diluted the deposit mix, pulling the blended yield down. Loan growth itself decelerated: ex-FCNR, loans grew 24% year-on-year, versus 30% reported. Deposit growth ex-FCNR? 17% year-on-year—less than half the reported 27.1%.
The increase in proportion of assets of overseas branches in the total assets and large sequential increase in the retail term deposit base have led to a moderation in margins. Full impact would reflect in Q3, after which we expect margins to start moving back up.
This is the tension: the FCNR funded 6% of the reported loan growth. Strip it out, and core growth is solid but not the outlier the headlines suggest. More troubling: management now says the full margin hit from this deposit mobilization will show in Q3 averages, with recovery expected only from Q4 onwards—and that recovery assumes the interest-rate cycle peaks immediately. It doesn't assume rate cuts; it assumes no further hikes.
NII grew 17.7% YoY
Delivered NII +17.7%; margin compression offset by loan volume
Supported
Loan portfolio grew 30% YoY
Yes; but ex-FCNR only 24% YoY, and FCNR carries lower yields
Overstated (composition)
PAT grew 20.1% YoY
Delivered: PAT +21.4% YoY (beat the on-call guidance)
Supported (beat)
Deposits grew 27.1% YoY
Yes; but ex-FCNR only 17% YoY, a significant miss on organic
Overstated (composition)
Margins are stable; pressure is only from deposit mix
NIM fell from 4.36% to 4.18% (18 bps). Mix is part of it; overseas branches and retail term deposits are headwinds
Contradicted (magnitude underplayed)
What changed on this call
Deposit strategy shifted overseas-heavy. FCNR ($18B) and overseas branches now >7% of assets—a structural mix shift, not a one-quarter event
Guidance stance reaffirmed: no numerical FY27 targets. Management cited macro uncertainty, consistent with last year, but this limits investor visibility into margin recovery timing
Loan growth accelerated, but not as structural as it appears. Ex-FCNR growth of 24% is solid but implies margin-funded expansion, not organic balance-sheet growth
Credit costs normalized lower. Provisioning fell to ₹8.51 crore (4.1% of PBT) vs. ₹9.14 crore a year prior; normalized credit cost of ~50 bps is better than the prior 60–80 bps band
Agri portfolio remediation still in RBI negotiation; provision reversal timing unclear, could slip to FY28
How the street is positioned
The stock sits at ₹1,394.20, above its 20-, 50-, and 200-day moving averages, but 7% below its all-time high of ₹1,500 and +17.4% above its 52-week low of ₹1,187.60. The price action suggests the market has already priced in a lot of the Q2 strength: the stock was drifting into the result, not screaming for it.
But here's what's striking: FII ownership jumped 15.33 percentage points quarter-on-quarter, from 34.49% in FY26 Q4 to 49.82% in FY27 Q1—a massive single-quarter inflow. DII also ticked up (+2.36pp). This looks like positioning ahead of the call or on the first whisper of the FCNR deal. The latest block activity shows a ₹1,343-crore trade (19+ million shares) between PI Opportunities and Pioneer Investment Fund in June, and a government pension fund repositioning in late June—institutional rebalancing, not panic or insider dumping. The ownership shift is bullish in isolation, but it also means the bar for upside surprises is higher now.
1 · Margin recovery depends on rate-cycle completion
Management expects NIM improvement from Q4 only if the repo rate peaks soon. If the RBI continues tightening or macro pressure keeps rates elevated, the margin trough extends, compressing FY27 and FY28 earnings. This is not just a Q3 headwind; it's a multi-quarter risk.
2 · Core growth (ex-FCNR) may be slowing faster than margins
At 24% loan growth and 17% deposit growth ex-FCNR, ICICI is growing faster than system average, but the gap is narrowing. If macro slowdown hits, these rates could decelerate further, forcing management to cut growth guidance and compress profitability. The 'risk-calibrated' stance may shift from growth to preservation.
3 · FCNR refinancing risk
The $18B FCNR is a 3-to-5-year instrument. If USD interest rates fall or FX volatility spikes, outflows are possible. Refinancing at maturity could be at higher cost. This is a structural liability, not as stable as management implies.
4 · Agri portfolio provision reversal timing uncertain
RBI is still reviewing ICICI's agri standard-asset provisioning. Until reversal is cleared (expected 2 quarters from the call, but timeline could slip), FY27–28 earnings have a hidden contingency.
5 · Valuation at peak with FII load already in
The stock is 7% below ATH but 17% above the 52-week low. FII has loaded up significantly (49.82% of float). Room for upside surprises is limited; downside (if margins surprise worse, or Q4 recovery stalls) is unhedged.
What to watch next
Q3 results (Expected Nov–Dec 2026): Is NIM compression as bad as management guided (further moderation from Q2's 4.18%)? Core loan and deposit growth trajectory—are they decelerating? Treasury losses or gains (Q2 had a ₹230-crore loss; recurring mark-to-market risk).
RBI agri-portfolio update (Expected Q4 FY27–Q1 FY28): Provision reversal clarity. If it happens, FY27 earnings get a one-time boost. If delayed to FY28, it's a drag on FY27 growth expectations.
FCNR deployment traction (Visible in subsequent calls): Are the proceeds funding high-yield loans, or sitting in lower-return securities? Deployment speed will determine whether Q4 margin recovery is real or pushed further out.
ICICI Bank is not a turnaround; it's a fortress franchise with clean credit and strong execution. Q2 proves it. But this quarter is also a study in how one-off items—in this case, $18 billion in foreign deposits—can make a moderating core look like a breakout.
The bank's real earnings power lies in the organic 24% loan growth, 17% deposit growth, and pristine 0.30% NPA ratio. That's enviable. But the margin compression is real, and management's refusal to quantify the recovery path is a yellow flag. Expect Q3 to be painful, and Q4 to be the test case for whether the turnaround is real or deferred.
The single number to track from here: NIM in Q3. If it falls below 4.1%, core earnings power is under pressure. If it stabilizes near 4.15%, management's Q4 recovery thesis becomes credible. Until then, the stock is a hold, not a buy.
Informational and educational content only. Not investment advice.